Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

China · Delayed Price · Currency is CNY

17.53

+1.49 (9.29%)

Nov 6, 2026, 9:25 AM CST

Market Cap	4.37B -49.6%
Revenue (ttm)	3.04B +7.5%
Net Income	96.06M -48.7%
EPS	0.39 -49.0%
Shares Out	249.40M
PE Ratio	45.25
Forward PE	22.12
Dividend	0.16 (0.91%)
Ex-Dividend Date	May 12, 2026

Volume	76,289
Open	16.99
Previous Close	16.04
Day's Range	16.99 - 17.53
52-Week Range	14.25 - 43.60
Beta	0.41
Analysts	Strong Buy
Price Target	36.03 (+105.53%)
Earnings Date	Oct 28, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2005

Employees 2,252

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688639

Full Company Profile

Financial Performance

In 2025, SHA:688639's revenue was 2.86 billion, an increase of 31.40% compared to the previous year's 2.18 billion. Earnings were 132.41 million, a decrease of -30.13%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 688639 stock is "Strong Buy." The 12-month stock price target is ¥36.03, which is an increase of 105.53% from the latest price.

Price Target

¥36.03

(105.53% upside)

Analyst Consensus: Strong Buy

Stock Forecasts